Thank you to our Foundational and Sustaining members
CHICAGO, IL – April 20, 2021 – physIQ, a leader in real-world biosensor data collection and digital biomarkers, today announced a new multi-year collaboration to license physIQ’s accelerateIQTM to Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The relationship allows Janssen to scale the use of biosensors, supporting initiatives across both R&D and commercial strategies. With […]
A visionary leader with a demonstrated ability to craft innovative strategies, build exceptional management teams and manage to results in a fast-changing business environment, Gary is the Chairman, CEO and Founder. Prior to physIQ, he was the founding CEO and Chairman of SmartSignal Corporation (now part of GE), a Chicago-based enterprise software firm, incubated by the University of […]
CHICAGO, IL – February 9, 2021 – physIQ, Inc. and the US Department of Veteran’s Affairs (VA) have advanced their collaboration to address heart failure care to an interventional trial phase. In this next phase, Veterans will be actively monitored so care can be administered in near real-time to avoid or lower the chance of re-hospitalization, allowing the […]
Flywheel Lands $15M in Series B Financing UnitedHealth Names Former Glaxo CEO Witty to Lead Company Minneapolis Biotechnology Firm Bio-Techne Saw Dividends on Growth HistoSonics Announces First Patient Treated in U.S. Clinical Study of Novel Sonic Beam Therapy for Liver Tumors PhysIQ Hires Scripps Research Translational Institute Doctor as Chief Medical Officer Tech Behind Pet […]
CHICAGO, IL – February 2, 2021 – Dr. Steve Steinhubl, a leader in reinventing medicine through the convergence of healthcare and technology and an expert in physiology, has joined physIQ as Chief Medical Officer. Dr. Steinhubl will help advance the adoption of physIQ’s artificial intelligence (AI)-based analytics for improved clinical outcomes and lower costs. “Over the last […]
CHICAGO, IL – January 28, 2021 – PhysIQ, Inc. will mark 2020 as a very important year-to-date for the leader in furthering acceptance and adoption of its digital medicine platform. Throughout the year, announcements of breakthrough studies and publications, important partnerships and collaborations, and an additional FDA clearance, were just a few of the notable accomplishments for this innovative […]
Cardialen Awarded $2.8 Million Federal Grant to Advance Therapy Designed to Treat Dangerous Heart Rhythms Boston Scientific Buying Minnesota Med-tech Firm Preventice Philips Acquires Capsule Technologies and its Medical Device Data Tech CHF Solutions Appoints Nestor Jaramillo, Jr. as President and Chief Executive Officer How Mayo Clinic Sparks Business Innovation in Rochester, Minnesota Med-tech Firm […]
A first-in-kind tool that collects and analyzes continuous physiologic data could provide early clinical indicators of COVID-19 decompensation. Based on Phase I data, machine learning was used to develop and test a novel COVID-19 digital biomarker to be further validated in Phase II. CHICAGO, IL – The National Cancer Institute (NCI) and the National Institute of […]
HistoSonics Receives Approval to Begin European #HOPE4LIVER Clinical Study Steris to Acquire Cantel Medical in $4.6B Deal Recombinetics Inc. Announces Neurofibromatosis Type 1 Research Collaboration with AstraZeneca OX2’s New Treatment for Central Nervous System Tumors Enters Phase I Clinical Trials Health, Tech Groups Aim to Create Digital Covid ‘Vaccination Passport’ Respicardia Announces Highmark Coverage for the […]
The Observer names physIQ as one of the hottest tech companies in the US second straight year for outstanding work amid the global COVID-19 pandemic. CHICAGO, IL – January 14, 2021 – PhysIQ, the leader in digital health solutions and artificial intelligence (AI) based physiology analytics, has been named to the Observer’s list of Hottest Health Tech Companies in Digital Health […]